S. E. Berkey1, D. L. Bartlett1, N. Obermajer1 1University Of Pittsburgh,Department Of Surgery,Pittsburgh, PA, USA
Introduction: Regulatory T (Treg) cells are integral in maintaining immune homeostasis and are associated with the inflammatory immunosuppression observed in cancer. Expansion of Treg cells within the tumor is a known barrier to successful cancer immunotherapy. In previous experiments, we have demonstrated that Th17 cells are a novel source of tumor-induced forkhead box P3 (Foxp3+) cells in addition to the natural (n)Treg and induced (i)Treg cells, which develop from naïve precursors. During tumor growth, Th17 cells progressively transdifferentiate into IL17+Foxp3+ and ex-Th17 IL17negFoxp3+ T cells. Here, we aimed to characterize the immunosuppressive ability of the ex-Th17 IL17negFoxp3+ T cells.
Methods: Using novel Th17eYFP-Foxp3mRFP reporter mice, CD4+ cells were isolated from splenocytes. The cells were cultured under Th17-driving conditions (IL6, IL23, and TGF-β) for 3-4 days, followed by Treg– driving conditions (TGF-β) for an additional 3 days, and then sorted into Th17-Treg subsets (eYFP+IL17+Foxp3neg, eYFP+IL17+Foxp3+, eYFP+IL17negFoxp3neg, eYFP+IL17negFoxp3+, eYFPnegIL17negFoxp3neg and eYFPnegIL17negFoxp3+ (inducible (i)Treg cells)). CD4+ cells were then isolated from CD45.1 mice and stained with the proliferation dye, carboxyfluorescein succinimidyl ester (CFSE). These CD4+ cells were activated with anti-CD3e Ab in the presence of CD4neg fraction and Th17-Treg subsets (2:1 ratio of CD4+ target cells: Th17-Treg subset). The cells were incubated for 72 hours and then analyzed by flow cytometry. The percentage of proliferating cells (CFSEneg, gated on live/CD45.1+CD4+ cells) was calculated as a fraction of proliferating cells compared to control condition where CD4+ cells were activated with anti-CD3e Ab in the absence of Th17-Treg subsets.
Results: We demonstrate that IL17+Foxp3+ and ex-Th17 IL17negFoxp3+ T cells have greater suppressive effects on CD4+ T cell proliferation compared to Th17 cells and have similar suppressive effects as (i)Treg cells.
Conclusions: The conversion of Th17 into Foxp3+ T cells is an alternative route of IL17+Foxp3+ and IL17negFoxp3+ T cell development in tumors. Due to their immunosuppressive properties, transdifferentiated Treg cells represent a novel target and warrant new therapeutic approaches aimed at eliminating Foxp3+ T cells in tumor immunotherapy.